These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25820461)

  • 1. Recent progress on pyrazole scaffold-based antimycobacterial agents.
    Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
    Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline: a promising antitubercular target.
    Keri RS; Patil SA
    Biomed Pharmacother; 2014 Oct; 68(8):1161-75. PubMed ID: 25458785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole: A Promising Antitubercular Agent.
    Keri RS; Patil SA; Budagumpi S; Nagaraja BM
    Chem Biol Drug Des; 2015 Oct; 86(4):410-23. PubMed ID: 25643871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
    Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
    Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Khalilullah H; Bakht MA; Hassan MZ
    Eur J Med Chem; 2011 Nov; 46(11):5694-7. PubMed ID: 21978838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and biological screening of pyrazole-conjugated benzothiazole analogs.
    Bhat M; Belagali SL
    Future Med Chem; 2018 Jan; 10(1):71-87. PubMed ID: 29235357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.
    Ramesh R; Shingare RD; Kumar V; Anand A; B S; Veeraraghavan S; Viswanadha S; Ummanni R; Gokhale R; Srinivasa Reddy D
    Eur J Med Chem; 2016 Oct; 122():723-730. PubMed ID: 27476117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
    Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
    Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
    ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole-core as an antimycobacterial agent.
    Keri RS; Rajappa CK; Patil SA; Nagaraja BM
    Pharmacol Rep; 2016 Dec; 68(6):1254-1265. PubMed ID: 27686965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
    Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
    Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
    Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.